Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 8 | 2025 | 94 | 2.800 |
Why?
|
| Laparoscopy | 16 | 2025 | 492 | 2.220 |
Why?
|
| Gastric Bypass | 11 | 2023 | 69 | 1.990 |
Why?
|
| Gastrectomy | 3 | 2025 | 39 | 1.770 |
Why?
|
| Bariatric Surgery | 3 | 2025 | 65 | 1.130 |
Why?
|
| Hernia, Hiatal | 2 | 2021 | 29 | 1.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 733 | 0.900 |
Why?
|
| Postoperative Hemorrhage | 1 | 2025 | 41 | 0.870 |
Why?
|
| Social Class | 1 | 2024 | 137 | 0.810 |
Why?
|
| Insulin Resistance | 7 | 2015 | 415 | 0.730 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 172 | 0.710 |
Why?
|
| Herniorrhaphy | 2 | 2021 | 71 | 0.570 |
Why?
|
| Weight Loss | 6 | 2023 | 275 | 0.430 |
Why?
|
| Blood Glucose | 2 | 2015 | 502 | 0.420 |
Why?
|
| Preoperative Care | 1 | 2015 | 199 | 0.400 |
Why?
|
| Retrospective Studies | 10 | 2025 | 6948 | 0.400 |
Why?
|
| Incidence | 3 | 2025 | 1432 | 0.350 |
Why?
|
| Obesity | 5 | 2015 | 1277 | 0.340 |
Why?
|
| Pancreatic Neoplasms | 5 | 2001 | 354 | 0.330 |
Why?
|
| Insulin | 3 | 2011 | 696 | 0.320 |
Why?
|
| Middle Aged | 17 | 2025 | 18434 | 0.300 |
Why?
|
| Heart Conduction System | 1 | 2009 | 50 | 0.300 |
Why?
|
| Adult | 15 | 2025 | 17508 | 0.300 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2007 | 52 | 0.290 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 54 | 0.280 |
Why?
|
| Male | 21 | 2025 | 31285 | 0.270 |
Why?
|
| Heart Rate | 1 | 2009 | 334 | 0.270 |
Why?
|
| Female | 20 | 2025 | 34298 | 0.260 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 31 | 0.250 |
Why?
|
| Humans | 31 | 2025 | 65635 | 0.250 |
Why?
|
| Adipose Tissue, Brown | 1 | 2007 | 126 | 0.230 |
Why?
|
| Peptic Ulcer | 2 | 2024 | 18 | 0.230 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 555 | 0.230 |
Why?
|
| Risk Factors | 3 | 2025 | 5466 | 0.230 |
Why?
|
| Glucose | 2 | 2007 | 478 | 0.220 |
Why?
|
| Learning Curve | 1 | 2025 | 33 | 0.220 |
Why?
|
| Postoperative Complications | 3 | 2015 | 1335 | 0.220 |
Why?
|
| Homeostasis | 1 | 2007 | 383 | 0.210 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2024 | 5 | 0.210 |
Why?
|
| Round Ligaments | 1 | 2023 | 2 | 0.200 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5818 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 93 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 202 | 0.170 |
Why?
|
| Surgical Mesh | 1 | 2021 | 60 | 0.170 |
Why?
|
| Esophagectomy | 1 | 2021 | 53 | 0.160 |
Why?
|
| Recurrence | 2 | 2021 | 664 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2001 | 178 | 0.160 |
Why?
|
| Kupffer Cells | 2 | 2015 | 43 | 0.150 |
Why?
|
| Body Mass Index | 5 | 2011 | 900 | 0.150 |
Why?
|
| Aspirin | 1 | 2000 | 172 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 2496 | 0.140 |
Why?
|
| Adipose Tissue, White | 2 | 2008 | 93 | 0.120 |
Why?
|
| Adipose Tissue | 2 | 2010 | 301 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 51 | 0.110 |
Why?
|
| Remission Induction | 1 | 2015 | 149 | 0.110 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 55 | 0.110 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 58 | 0.110 |
Why?
|
| Splenectomy | 2 | 2004 | 39 | 0.100 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 118 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 5 | 2001 | 426 | 0.100 |
Why?
|
| Adenocarcinoma | 3 | 2001 | 367 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2006 | 604 | 0.090 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 37 | 0.080 |
Why?
|
| Omentum | 1 | 2010 | 14 | 0.080 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 50 | 0.080 |
Why?
|
| Cell Division | 3 | 2001 | 450 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2000 | 213 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 113 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 140 | 0.080 |
Why?
|
| Prognosis | 1 | 2015 | 1791 | 0.080 |
Why?
|
| Laparotomy | 3 | 2024 | 56 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 195 | 0.080 |
Why?
|
| Sodium Salicylate | 2 | 1999 | 3 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2000 | 435 | 0.080 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 46 | 0.070 |
Why?
|
| I-kappa B Proteins | 2 | 1999 | 37 | 0.070 |
Why?
|
| Hernia | 1 | 2009 | 14 | 0.070 |
Why?
|
| Sex Factors | 2 | 2009 | 995 | 0.070 |
Why?
|
| Peritoneal Lavage | 1 | 2009 | 4 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 1116 | 0.070 |
Why?
|
| Colon, Sigmoid | 1 | 2009 | 13 | 0.070 |
Why?
|
| Gastroplasty | 1 | 2008 | 14 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 405 | 0.070 |
Why?
|
| Diverticulitis | 1 | 2009 | 38 | 0.070 |
Why?
|
| Wounds, Stab | 1 | 2008 | 13 | 0.070 |
Why?
|
| Age Factors | 2 | 2009 | 1592 | 0.070 |
Why?
|
| Abdominal Injuries | 1 | 2008 | 32 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 152 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 40 | 0.070 |
Why?
|
| Immunoassay | 1 | 2007 | 71 | 0.060 |
Why?
|
| Radiography | 1 | 2009 | 558 | 0.060 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 116 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2000 | 611 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 99 | 0.060 |
Why?
|
| Triglycerides | 1 | 2008 | 248 | 0.060 |
Why?
|
| RNA Interference | 2 | 2008 | 647 | 0.060 |
Why?
|
| Length of Stay | 3 | 2024 | 828 | 0.060 |
Why?
|
| Comorbidity | 1 | 2009 | 1120 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2007 | 193 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 75 | 0.060 |
Why?
|
| Nephrectomy | 1 | 2006 | 93 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 449 | 0.050 |
Why?
|
| Contrast Media | 1 | 2007 | 432 | 0.050 |
Why?
|
| Splenomegaly | 1 | 2004 | 22 | 0.050 |
Why?
|
| Splenic Diseases | 1 | 2004 | 14 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 565 | 0.050 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2004 | 14 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 992 | 0.050 |
Why?
|
| Apoptosis | 2 | 1999 | 1100 | 0.050 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2003 | 4 | 0.050 |
Why?
|
| Macrophages | 2 | 1999 | 1041 | 0.050 |
Why?
|
| G1 Phase | 2 | 2001 | 58 | 0.050 |
Why?
|
| Inflammation | 1 | 2010 | 1195 | 0.050 |
Why?
|
| Adrenalectomy | 1 | 2003 | 26 | 0.050 |
Why?
|
| S Phase | 2 | 2001 | 79 | 0.050 |
Why?
|
| Massachusetts | 1 | 2009 | 2154 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2003 | 130 | 0.050 |
Why?
|
| Spleen | 1 | 2004 | 476 | 0.050 |
Why?
|
| Cell Separation | 2 | 2000 | 147 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 131 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2009 | 3328 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2009 | 2113 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2008 | 718 | 0.040 |
Why?
|
| Immunophilins | 1 | 2001 | 1 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2001 | 664 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 10 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 46 | 0.040 |
Why?
|
| Chromones | 1 | 2000 | 18 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2000 | 115 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2024 | 436 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2000 | 17 | 0.040 |
Why?
|
| Flavonoids | 1 | 2000 | 57 | 0.040 |
Why?
|
| Morpholines | 1 | 2000 | 91 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 23 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1999 | 42 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 35 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2006 | 963 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 1662 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 87 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1999 | 27 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 96 | 0.040 |
Why?
|
| Young Adult | 1 | 2009 | 4855 | 0.040 |
Why?
|
| Ischemia | 1 | 2000 | 203 | 0.030 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 625 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2000 | 222 | 0.030 |
Why?
|
| Endotoxins | 1 | 1999 | 81 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2003 | 731 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2000 | 398 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 2252 | 0.030 |
Why?
|
| Aged | 4 | 2009 | 15087 | 0.030 |
Why?
|
| Adipocytes | 2 | 2010 | 275 | 0.030 |
Why?
|
| Animals | 7 | 2015 | 21450 | 0.030 |
Why?
|
| Liver | 1 | 2000 | 874 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 80 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 160 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 97 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2015 | 38 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 3500 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 87 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 491 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2015 | 115 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2008 | 593 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 225 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 460 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 216 | 0.020 |
Why?
|
| Mice | 3 | 2015 | 11172 | 0.020 |
Why?
|
| Swine | 2 | 2006 | 397 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2006 | 323 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 436 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2006 | 2189 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 333 | 0.020 |
Why?
|
| Mutation | 1 | 2000 | 2670 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1580 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2011 | 5 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2001 | 3162 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 964 | 0.020 |
Why?
|
| Chemokines | 1 | 2010 | 99 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 1999 | 25 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2000 | 391 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 514 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 624 | 0.020 |
Why?
|
| Perilipin-1 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 178 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 987 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 90 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 208 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 50 | 0.020 |
Why?
|
| Lipolysis | 1 | 2008 | 47 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 77 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 307 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2008 | 224 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 854 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 60 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 427 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 52 | 0.020 |
Why?
|
| Rats | 2 | 2000 | 1996 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 89 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 30 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 376 | 0.010 |
Why?
|
| Abdomen | 1 | 2006 | 97 | 0.010 |
Why?
|
| Time Factors | 2 | 2006 | 3777 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1588 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1172 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1979 | 0.010 |
Why?
|
| Palpation | 1 | 2004 | 9 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 25 | 0.010 |
Why?
|
| Hand | 1 | 2004 | 77 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 441 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2004 | 59 | 0.010 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2004 | 128 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1226 | 0.010 |
Why?
|
| Proteins | 1 | 2008 | 764 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2639 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 792 | 0.010 |
Why?
|
| Mitogens | 1 | 2001 | 10 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2001 | 10 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2001 | 38 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 38 | 0.010 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2000 | 14 | 0.010 |
Why?
|
| Sirolimus | 1 | 2001 | 93 | 0.010 |
Why?
|
| Bile | 1 | 2000 | 19 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 2000 | 16 | 0.010 |
Why?
|
| Reperfusion | 1 | 2000 | 37 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2001 | 132 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2000 | 51 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2001 | 153 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1633 | 0.010 |
Why?
|
| Ibuprofen | 1 | 1999 | 17 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 34 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1999 | 42 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 344 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1999 | 3 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1999 | 134 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1999 | 33 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 149 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 588 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1999 | 634 | 0.010 |
Why?
|
| Cell Line | 1 | 1999 | 2029 | 0.010 |
Why?
|